Our Portfolio
MEC develops point-of-care diagnostic products that enable real-time measurement of key blood analysis for early detection of a variety of diseases including diabetes, cardiovascular diseases and cancer. Its key product, Avie A1c is the FDA-approved diagnostic kit for diabetic patients.
The company is led by the President and CEO, Emmanuel Mpock, who has founded companies on his diagnostic invention that have been FDA approved for clinical sale.

The Director of Product Development, Wilma Miller Magan, has over 20 years in the development of multiple diagnostics products and is listed in numerous patents and contributed to numerous scientific journals.
Visit Website